跳至主要内容
临床试验/ACTRN12622000470796
ACTRN12622000470796尚未招募未知

Efficacy and safety of Levetricetam Versus Phenytoin for Neonatal Seizures: A Randomized Controlled Trial

DR KHWAJA KAMRAN WAJID0 个研究点目标入组 184 人开始时间: 2022年3月25日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
184

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment

入排标准

年龄范围
1 Hours 至 30 Days(—)
性别
All

入选标准

  • Neonates till 30 days of life both male/female with seizures.

排除标准

  • Neonates with hypoglycemia, hypocalcemia, hypomagnesemia, those who received anticonvulsants prior to enrolment, and those with major congenital malformations e.g., congenital heart defects, neural tube malformations, diaphragmatic hernia, choanal atresia, esophageal atresia, tracheoesophageal
  • fistula, omphalocele, gastroschisis, intestinal obstruction and imperforate anus) were excluded.

研究者

发起方
DR KHWAJA KAMRAN WAJID

相似试验